BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35743206)

  • 21. Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin.
    Hsu HC; Liu LC; Wang HY; Hung CM; Lin YC; Ho CT; Way TD
    PLoS One; 2017; 12(1):e0164661. PubMed ID: 28060811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
    Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
    Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
    Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS
    Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549 
by Supressing Stat3-EMT via CAFs Exosomes].
    Wang S; Cui J; Zhang K; Gu J; Zheng Y; Zhang B; Shi L
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):384-393. PubMed ID: 34024061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells.
    Josan C; Podinic T; Pfaff N; Raha S
    PLoS One; 2022; 17(8):e0272819. PubMed ID: 35976913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
    Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
    Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of delta-9-tetrahydrocannabinol and cannabidiol on p50 of the oxygen haemoglobin dissociation curve.
    James TR; Watson CT; Pepple DJ
    Fitoterapia; 2020 Jun; 143():104539. PubMed ID: 32147492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of cannabidiol and Δ9-tetrahydrocannabinol, alone and in combination, in the maximal electroshock seizure model.
    Dlugosz L; Zhou HZ; Scott BW; Burnham M
    Epilepsy Res; 2023 Feb; 190():107087. PubMed ID: 36646020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice.
    Liu J; Scott BW; Burnham WM
    Behav Pharmacol; 2022 Apr; 33(2&3):206-212. PubMed ID: 33883447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
    Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
    Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.
    Pintori N; Caria F; De Luca MA; Miliano C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
    Jamontt JM; Molleman A; Pertwee RG; Parsons ME
    Br J Pharmacol; 2010 Jun; 160(3):712-23. PubMed ID: 20590574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
    Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
    Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
    Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
    Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
    J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.